Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance | Eli Lilly and Company - Investors | Eli Lilly and Company


1/14/2025

Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance | Eli Lilly and Company  Investors | Eli Lilly and CompanyEli Lilly forecasts weaker Q4 sales of weight-loss drug, Mounjaro than expected  Yahoo FinanceLilly 2024 Sales Miss Estimate as Weight-Loss Drugs Slow  BloombergEli Lilly issues Q4 2024 revenue guidance below consensus (LLY:NYSE)  Seeking AlphaEli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand  CNBC...

Original

Categories: Drugs | Financial | Health | Revenue

Tags: announces | company | cuts | drop | drug | drugs | guidance | investors | issues | loss | miss | sales | shares | update



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top